U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07781683) titled 'Clinical Evaluation of Salivary 1,5-Anhydroglucitol in Diabetes' on Aug. 20.
Brief Summary: The goal of this observational study is to evaluate the clinical value of salivary 1,5-anhydroglucitol (1,5-AG) and assess a novel noninvasive detection approach in individuals with and without type 2 diabetes. Additionally, the study will examine the relationships of salivary 1,5-AG with serum 1,5-AG and continuous glucose monitoring (CGM) measures of short-term glycemic control and fluctuations.
Study Start Date: Sept. 01
Study Type: OBSERVATIONAL
Condition:
Type 2 Diabetes (T2DM)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shangh...